Medical researches revealed the potential of ultrasound to help treating type 2 diabetes


Bioelectronic medicine could help in the future the patients with diabete. Treating diabetes without drugs is for the moment a dream. But a multi-institutional team including Yale School of Medicine and the lab of Raimund Herzog, MD, MHS, at YSM has demonstrated the ability to use ultrasound to stimulate specific neurometabolic pathways in the body to prevent or reverse the onset of type 2 diabetes in three different preclinical models. The goal of the studies is to provide long-lasting treatment for people with type 2 diabetes, millions of people worldwide, to alleviate and potentially reverse the disease. This could be an effective, noninvasive, drug-free way to boost insulin levels in people with type 2 diabetes. Herzog, associate professor (endocrinology) in the Department of Internal Medicine at YSM and a member of the NIH-funded Yale Diabetes Research Center, and his lab tested the magnitude of the effect of ultrasound treatment on blood glucose.


“If our ongoing clinical trials confirm the promise of the preclinical studies reported in this paper, and ultrasound can be used to lower both insulin and glucose levels, ultrasound neuromodulation would represent an exciting and entirely new addition to the current treatment options for our patients,” his team concluded. The study is ongoing to test and clarify various aspects. New conclusions are expected later this year. Researchers at George Washington University in Washington, D.C., are also investigating an innovative way to treat diabetes based on ultrasound. Although the results are fascinating and likely to generate discussion, these are very early days.